Chief Executive Officer
Tue, Jan 16, 2024
Jan 16
received an award in APLS
72,094 shares @ $0.00
Increased holdings by +26.70%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology